Interactive video plus navigator to help Black women get cervical cancer screening
Official title: Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women
Run by ISA Associates, Inc. · NCT07011836 · Data updated 2026-11-12
This project will test whether an interactive video paired with an in-person navigator helps Black women who are overdue get cervical cancer screening more often than a standard educational video.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 65 Years |
| Sex | Women only |
| Enrollment | 288 (estimated) |
| Sponsor | ISA Associates, Inc. Academic / other |
| Locations | 2 sites (Washington D.C., District of Columbia and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | January 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | April 21, 2026 |
| Trial ID | NCT07011836 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Black or African American women ages 21–65 who are overdue for Pap or HPV screening, are not pregnant, have not had a hysterectomy, and have a mobile phone that can receive texts and play videos.
✕Probably not a fit
Women who are already up to date with cervical screening, who are pregnant, who have had a hysterectomy, or who lack access to a text/video-capable mobile phone are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized intervention compares an interactive, tailored video program (mNav) delivered with in-person patient navigation to a standard educational video among Black/African American women overdue for cervical cancer screening. Participants are randomly assigned to one of the two video conditions and complete phone surveys at enrollment and six months to measure screening adherence, knowledge, barriers, and intentions. The intervention arm receives an on-screen guided interactive video plus in-person navigation support while the control arm views a standard educational video. Recruitment and enrollment are conducted through community clinic sites in Washington, D.C. and Arlington, VA with ISA Associates leading the project and NIMHD as a collaborator.
Why it matters
Potential benefit: If successful, the approach could increase screening uptake in an underserved group and help detect cervical disease earlier.
How similar studies have gone: Previous patient-navigation and tailored digital messaging programs have shown promising improvements in screening rates in underserved populations, though results have varied by setting and implementation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Black or African American woman * Nonadherent to USPSTF cervical cancer screening guidelines (no Pap test in the past 3 years or no HPV test in the past 5 years) * Age 21 to 65 years old * Not currently pregnant * No history of hysterectomy * Access to a mobile phone capable of receiving text messages and watching video content Exclusion Criteria: \*None
Where it's running
-
Family and Medical Counseling Service, Inc.
Washington D.C., District of Columbia, United States Recruiting -
ISA Associates
Arlington, Virginia, United States Not yet recruiting
Study contacts
- Study coordinator: Douglas Billings, PhD
- Email: dbillings@isagroup.com
- Phone: 7037390882
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Enlonstobart with chemotherapy and radiotherapy for locally advanced cervical cancer
This study tests whether adding Enlonstobart to standard chemotherapy and chemoradiotherapy helps patients with locally advanced cervical cancer by increasing response rates and monitoring safety.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Immunotherapy Plus Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer
This trial tests whether adding immunotherapy and chemotherapy to carbon ion radiotherapy can help women with locally advanced cervical cancer live longer without the cancer growing.
-
Dual PD1/CTLA4 immunotherapy with chemotherapy before surgery for locally advanced cervical cancer
This study tests a combo of a PD1/CTLA4 bispecific antibody with standard chemotherapy to see if it can improve outcomes before surgery in women with locally advanced cervical cancer.
-
Radiomic MRI model to predict response to chemoradiotherapy in locally advanced cervical cancer
This project tests whether MRI-based radiomic features can predict how women with locally advanced cervical cancer will respond to combined chemotherapy and radiation.
-
Post-therapy stress symptoms after gynecologic brachytherapy in cervical cancer
This study tests whether patients undergoing uterovaginal brachytherapy for cervical cancer develop post-traumatic stress symptoms and how these symptoms change over up to 5 years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.